Unusual Surge in Alkaline Phosphatase During Pregnancy A Case Report on Diagnostic Challenges

Introduction

Understanding ALP in Pregnancy

Alkaline phosphatase is an enzyme found in multiple tissues, including the liver, bones, and placenta. During pregnancy, ALP naturally increases due to placental contributions, often doubling in the third trimester. However, this case highlighted a rare spike far beyond normal physiological levels.

  • Patient: 21-year-old, 34 weeks pregnant, first-time mother
  • ALP Level: Peaked at 4001 U/L normal: 33–120 U/L
  • Symptoms: Mild right upper quadrant tenderness
  • Fetal Status: Normal vital signs; no abnormalities on ultrasound
  • Medical History: No prior bone, renal, or liver disease

Key Case Details and Clinical Findings

The patient’s blood work revealed no significant abnormalities apart from ALP. Liver, renal, and endocrine panels were within normal limits. Postpartum decline in ALP was observed over seven weeks, aligning with literature that suggests normalization between 6 to 12 weeks after delivery.

  • No liver or biliary pathology found
  • Baby delivered vaginally with healthy Apgar scores 7 and 9
  • Placental histology showed mild chorioamnionitis
  • ALP normalized to 103 U/L at week 7 postpartum

Implications for Clinical Practice

  • Placental insufficiency
  • Potential risk for low birth weight
  • Predictive marker of adverse outcomes

According to studies, acutely rising ALP could reflect underlying placental injury, and in some cases, infarctions or chronic inflammation such as chorioamnionitis.

Further Reading and Access to Study

Call-to-Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.